ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments (ED2PrEP)
Primary Purpose
HIV
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PVO
TS
Sponsored by
About this trial
This is an interventional prevention trial for HIV
Eligibility Criteria
Inclusion Criteria:
- 18 years and older;
- visit to the Emergency Department,
- has a sexual health related concern
Exclusion Criteria:
- unable to provide informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Post Visit Outreach
Tele-Sexual Healthcare
Arm Description
Outreach by trained patient navigators/educators after patients' ED visit for education, counseling, linkage to preventive/sexual health care.
Tele-sexual health visit with a specialist offered during the ED visit to patients.
Outcomes
Primary Outcome Measures
PrEP Uptake
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
Secondary Outcome Measures
PrEP Uptake at 6 months
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
PrEP Uptake at 12 months
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
Linkage to status neutral healthcare
Attending a clinical appointment for sexual healthcare or related to HIV, captured in the electronic health record
Linkage to status neutral healthcare
Attending a clinical appointment for sexual healthcare or related to HIV, captured in the electronic health record
HIV and STI testing
Receipt of tests for HIV and sexually transmitted infections (gonorrhea and chlamydia from any anatomic site, or syphilis) after the emergency department visit, captured in the electronic health record.
PrEP Persistence
Composite data from the electronic health record about having a prescription for PrEP medications and survey responses about current PrEP use.
PrEP Persistence
Composite data from electronic health record about having a prescription for PrEP medications and survey responses about current PrEP use.
HIV Viral RNA levels
Laboratory quantification of circulating HIV virus among individuals diagnosed with HIV in the study.
HIV Viral RNA levels
Laboratory quantification of circulating HIV virus among individuals diagnosed with HIV in the study.
Incident HIV Diagnosis
Diagnosis of HIV based on multiple data sources (electronic health record, surveys) occurring at anytime starting from ED visit through end of study period.
Full Information
NCT ID
NCT05588193
First Posted
October 7, 2022
Last Updated
October 18, 2022
Sponsor
Viraj V. Patel
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
1. Study Identification
Unique Protocol Identification Number
NCT05588193
Brief Title
ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments
Acronym
ED2PrEP
Official Title
ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments Patients: a Cross-over Hybrid Implementation Effectiveness Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
April 2025 (Anticipated)
Study Completion Date
July 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Viraj V. Patel
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Severe inequities in HIV pre-exposure prophylaxis (PrEP) access and use in communities hardest hit by the HIV epidemic persist, further exacerbating ongoing racial/ethnic and socioeconomic disparities in HIV incidence. In these same communities, many patients at risk for HIV seek care for sexually transmitted infections (STIs) in Emergency Departments (EDs), but the structure of traditional ED care is poorly suited to address HIV prevention or provide PrEP. To advance the Prevent objective of the Ending the HIV Epidemic (EHE) initiative, ED2PrEP will leverage an implementation science approach to rigorously test two innovative strategies for increasing PrEP uptake among patients seeking STI care in EDs in one of the 48 EHE-identified geographic hotspots.
Detailed Description
Severe inequities in HIV pre-exposure prophylaxis (PrEP) access and use persist among Black and Latinx communities most impacted by the HIV epidemic. The Bronx, NY, with over 90% of the population identifying as Black or Latinx, is an Ending the HIV Epidemic (EHE) priority county with the fifth highest HIV diagnosis rate in the U.S. and the lowest PrEP use in NY. Research on barriers to PrEP engagement indicate that the current structure of PrEP access and management is not consonant with the lives, priorities, or needs of the hardest hit communities, further exacerbating ongoing racial/ethnic and socioeconomic disparities in HIV incidence. Many of the same barriers leading to poor PrEP uptake in Black/Latinx communities also drive members of these communities to seek care for sexually transmitted infections (STIs), a known risk factor for HIV, in Emergency Departments (EDs). However, there is a discordance between the type of care likely to preserve the long-term health of those seeking STI care in EDs (longitudinal, behavioral, and prevention-oriented) and the care the ED is optimized to provide (acute, high intensity, life-saving/stabilizing), meaning that both patients and health systems stand to gain from a restructuring of how STI care is delivered in EDs. Innovative, efficient, and sustainable strategies for identifying and engaging high priority populations for HIV prevention seeking sexual healthcare in EDs are thus needed. The study team therefore proposes ED2PrEP, a pragmatic Type III hybrid effectiveness-implementation trial comparing two strategies for increasing PrEP uptake among patients at risk for HIV accessing care in Bronx EDs. The two strategies are (1) Post-Visit Outreach (PVO) involving proactive outreach to patients following a STI-related ED visit. PVO will be initiated by a Sexual Health Navigator who will provide PrEP education, counseling, and linkage to existing sexual health/PrEP clinics. (2) Tele-PrEP (TP) will involve a real-time telehealth visit with a Sexual Health Provider during STI-related ED visits. TP will also include education, counseling, and linkage, in addition to the provider's ability to prescribe PrEP at the time of the visit. To test the effectiveness of PVO and TP for increasing PrEP uptake among patients accessing STI care in the ED, the study team will perform a crossover trial in which the strategies are implemented in two different EDs for 9 months and then switched for another 9 months (Aim 1). Next, guided by the RE-AIM framework, the study team will assess implementation outcomes for the strategies to identify how each strategy's effectiveness is impacted by implementation considerations (Aim 2). Finally, to inform scale-out locally and nationally, the study team will perform an economic analysis to determine each strategy's cost per outcome and relative cost-effectiveness (Aim 3). ED2PrEP will generate critical data that could transform how EDs initiate PrEP and engage populations at the highest risk for HIV and accelerate EHE goals in one hardest hit jurisdictions in the U.S. Findings could also be informative to other jurisdictions, having dramatic effects on how HIV prevention is delivered.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Non-Randomized
Enrollment
1000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Post Visit Outreach
Arm Type
Experimental
Arm Description
Outreach by trained patient navigators/educators after patients' ED visit for education, counseling, linkage to preventive/sexual health care.
Arm Title
Tele-Sexual Healthcare
Arm Type
Experimental
Arm Description
Tele-sexual health visit with a specialist offered during the ED visit to patients.
Intervention Type
Behavioral
Intervention Name(s)
PVO
Intervention Description
post-visit outreach
Intervention Type
Behavioral
Intervention Name(s)
TS
Intervention Description
tele-sexual health visit during the ED visit
Primary Outcome Measure Information:
Title
PrEP Uptake
Description
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
PrEP Uptake at 6 months
Description
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
Time Frame
6 months
Title
PrEP Uptake at 12 months
Description
Prescription of any medication to be used as HIV PrEP, captured in the electronic health record.
Time Frame
12 months
Title
Linkage to status neutral healthcare
Description
Attending a clinical appointment for sexual healthcare or related to HIV, captured in the electronic health record
Time Frame
3 months
Title
Linkage to status neutral healthcare
Description
Attending a clinical appointment for sexual healthcare or related to HIV, captured in the electronic health record
Time Frame
12 months
Title
HIV and STI testing
Description
Receipt of tests for HIV and sexually transmitted infections (gonorrhea and chlamydia from any anatomic site, or syphilis) after the emergency department visit, captured in the electronic health record.
Time Frame
6 months
Title
PrEP Persistence
Description
Composite data from the electronic health record about having a prescription for PrEP medications and survey responses about current PrEP use.
Time Frame
6 months
Title
PrEP Persistence
Description
Composite data from electronic health record about having a prescription for PrEP medications and survey responses about current PrEP use.
Time Frame
12 months
Title
HIV Viral RNA levels
Description
Laboratory quantification of circulating HIV virus among individuals diagnosed with HIV in the study.
Time Frame
3 months
Title
HIV Viral RNA levels
Description
Laboratory quantification of circulating HIV virus among individuals diagnosed with HIV in the study.
Time Frame
12 months
Title
Incident HIV Diagnosis
Description
Diagnosis of HIV based on multiple data sources (electronic health record, surveys) occurring at anytime starting from ED visit through end of study period.
Time Frame
18 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18 years and older;
visit to the Emergency Department,
has a sexual health related concern
Exclusion Criteria:
unable to provide informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Uriel Felsen, MD, MS
Phone
7189208588
Email
ufelsen@montefiore.org
First Name & Middle Initial & Last Name or Official Title & Degree
Viraj V Patel, MD, MPH
Phone
7189205256
Email
vpatel@montefiore.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Uriel Felsen, MD, MS
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Viraj V Patel, MD, MPH
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
All deidentified participant level data related to study outcomes.
IPD Sharing Time Frame
6 months after publication of primary outcomes for 5 years.
IPD Sharing Access Criteria
Appropriate IRB approvals, research plans approved by study MPIs, and data sharing agreements executed.
Learn more about this trial
ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments
We'll reach out to this number within 24 hrs